Skip to main content
user-generated· event

Major pharma company acquires a biotech startup focused on gene editi…

The summit underscored the rapid advancements in gene editing, with several startups presenting preclinical data. Large pharmaceutical firms are under pressure to bolster their pipelines, and gene editing represents a high-growth opportunity. A strategic acquisition is a likely outcome within the next 9 months to secure competitive advantage.

event · Prediction Market

Implied probability (Yes)
68%

More event markets

Browse all event markets →

Loading…